Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.76B |
| 2 |
Tesla
TSLA
|
+$1.37B |
| 3 |
Amazon
AMZN
|
+$623M |
| 4 |
AbbVie
ABBV
|
+$398M |
| 5 |
Qualcomm
QCOM
|
+$394M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$603M |
| 3 |
Micron Technology
MU
|
+$366M |
| 4 |
Meta Platforms (Facebook)
META
|
+$365M |
| 5 |
UnitedHealth
UNH
|
+$353M |
Sector Composition
| 1 | Healthcare | 21.21% |
| 2 | Technology | 12.91% |
| 3 | Consumer Discretionary | 10.45% |
| 4 | Financials | 8.47% |
| 5 | Industrials | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2676
BBVA Argentina
BBAR
$1.99B
| $920K | ﹤0.01% |
165,182
-74,682
| -31% | -$416K |
|
2677
OneSpaWorld
OSW
$2.3B
| $916K | ﹤0.01% |
+54,400
| New | +$916K |
|
|
IMBI
2678
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
| $916K | ﹤0.01% |
229,496
+16,415
| +8% | +$65.5K |
|
2679
BGC Group
BGC
$4.86B
| $912K | ﹤0.01% |
153,548
-1,056,216
| -87% | -$6.27M |
|
|
CEQP
2680
DELISTED
Crestwood Equity Partners LP
CEQP
| $911K | ﹤0.01% |
29,556
+17,274
| +141% | +$532K |
|
2681
Vanguard Consumer Discretionary ETF
VCR
$6.53B
| $910K | ﹤0.01% |
+4,800
| New | +$910K |
|
|
FARO
2682
DELISTED
Faro Technologies
FARO
| $903K | ﹤0.01% |
+17,942
| New | +$903K |
|
2683
Commercial Metals
CMC
$6.57B
| $900K | ﹤0.01% |
+40,400
| New | +$900K |
|
2684
First Savings Financial Group
FSFG
$190M
| $899K | ﹤0.01% |
40,200
+6,300
| +19% | +$141K |
|
|
SYRS
2685
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $892K | ﹤0.01% |
12,909
-15,751
| -55% | -$1.09M |
|
|
ARGO
2686
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $892K | ﹤0.01% |
13,565
-25,100
| -65% | -$1.65M |
|
|
LBY
2687
DELISTED
Libbey, Inc.
LBY
| $891K | ﹤0.01% |
614,800
+105,100
| +21% | +$152K |
|
2688
AMREP Corp
AXR
$117M
| $885K | ﹤0.01% |
147,980
+15,700
| +12% | +$93.9K |
|
|
RLH
2689
DELISTED
Red Lions Hotel Corporation
RLH
| $882K | ﹤0.01% |
236,490
-102,200
| -30% | -$381K |
|
2690
Scully Royalty
SRL
$81.1M
| $880K | ﹤0.01% |
71,006
+4,236
| +6% | +$52.5K |
|
2691
Akebia Therapeutics
AKBA
$785M
| $875K | ﹤0.01% |
138,527
+95,100
| +219% | +$601K |
|
2692
Vanguard S&P 500 Growth ETF
VOOG
$19.8B
| $872K | ﹤0.01% |
+5,000
| New | +$872K |
|
|
PW
2693
Power REIT
PW
$3.42M
| $869K | ﹤0.01% |
96,558
+10,220
| +12% | +$92K |
|
|
KAMN
2694
DELISTED
Kaman Corp
KAMN
| $865K | ﹤0.01% |
13,122
-55,000
| -81% | -$3.63M |
|
|
CYRN
2695
DELISTED
CYREN Ltd.
CYRN
| $865K | ﹤0.01% |
33,771
+1,206
| +4% | +$30.9K |
|
|
KDMN
2696
DELISTED
Kadmon Holdings, Inc.
KDMN
| $864K | ﹤0.01% |
+190,800
| New | +$864K |
|
2697
Nine Energy Service
NINE
$30.8M
| $862K | ﹤0.01% |
110,200
+47,800
| +77% | +$374K |
|
|
OBSV
2698
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $856K | ﹤0.01% |
224,100
+136,100
| +155% | +$520K |
|
2699
Liberty Broadband Class C
LBRDK
$8.71B
| $855K | ﹤0.01% |
+6,800
| New | +$855K |
|
2700
Puma Biotechnology
PBYI
$233M
| $853K | ﹤0.01% |
+97,500
| New | +$853K |
|